Hwh breaking news

Here is some breaking news about HWH International:

1. Revenue Growth: HWH International has reported a 52% increase in revenue for the third quarter of 2024, reaching $345.5k compared to $226.9k in the same period last year. This indicates a strong performance in terms of sales and market presence.
2. Net Loss Widening: However, the company has also experienced a significant widening of its net loss, with a loss of $548.5k in the third quarter of 2024, a 248% increase from the $156.1k loss in the previous year. This suggests that while the company is growing its top line, it is facing substantial costs or challenges that are impacting its profitability.
3. Share Price Movement: Despite the revenue growth, the company's share price has remained largely unchanged from the previous week, reflecting market uncertainty or other factors influencing investor sentiment. This lack of movement in the share price could be due to various factors, including the net loss widening and the overall market environment.
4. Business Initiatives: HWH International has announced the launch of the Hapi Wealth program, which is set to provide comprehensive education in equity investment and wealth-building strategies. This initiative could be a key driver for the company's future growth, particularly if it is successful in attracting and retaining members.
5. Marketplace Launch: The company has also launched its proprietary business-to-consumer marketplace, Hapi Marketplace, offering a wide range of products across various categories. This expansion into the retail sector could potentially increase the company's revenue streams and customer base.
6. Listing Compliance: HWH International has been granted an extension to comply with Nasdaq's listing requirements, which includes maintaining the minimum market value of publicly held shares and minimum market value of listed securities. This extension allows the company to address its listing concerns and continue to operate in the wholesale drug industry.

In conclusion, HWH International has shown significant growth in revenue, but is facing challenges in terms of profitability and market perception, as evidenced by the widening net loss and lack of share price movement. The company's strategic initiatives, such as the Hapi Wealth program and the launch of Hapi Marketplace, could be pivotal in shaping its future performance. The extension on Nasdaq listing is a positive development that allows the company to rectify its listing concerns and continue its operations in the wholesale drug industry.